Fifth Third Bancorp
APGN

Fifth Third Bancorp’s Apexigen, Inc. Common Stock APGN Stock Holding History

Fifth Third Bancorp’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,500
Closed -$4K – 2784
2022
Q3 		$4K Buy
+1,500
New +$12.2K ﹤0.01% 2282

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Fifth Third Bancorp's APGN Position: Q4 2022 in Review

Fifth Third Bancorp sold out of Apexigen, Inc. Common Stock (APGN) in Q4 2022, closing a stake of 1,500 shares — an estimated $4K sold.

Fifth Third Bancorp first reported a position in APGN in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 15 funds tracked by Wall St. Rank hold APGN as of Q4 2022.

  • Fifth Third Bancorp reported no remaining Apexigen, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,500 Apexigen, Inc. Common Stock shares in Q4 2022, an estimated $4K.
  • Fifth Third Bancorp first reported a position in Apexigen, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Fifth Third Bancorp's Apexigen, Inc. Common Stock position peaked at $4K in Q3 2022.
  • 15 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q4 2022.

Based on Fifth Third Bancorp's 13F filing for Q4 2022, filed 25 Jan 2023.